The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

The platform, which includes the new form factor CGM and the Simplera Sync sensor, is designed for integration with Medtronic ...

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient ...

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...

Growth prospects remain bright. As type 1 and type 2 diabetes continue inflicting people, Medtronic's solutions such as MiniMed (insulin pump), InPen (real-time continuous glucose monitoring and ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...